{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:23:41Z","timestamp":1787952221362,"version":"build-2784847793"},"reference-count":114,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.autrev.2023.103330","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T20:21:57Z","timestamp":1680898917000},"page":"103330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Renal involvement in systemic sclerosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Marc","family":"Scheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Dominati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samih","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"De Seigneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Haidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0005","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.autrev.2023.103330_bb0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0020","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000507886","article-title":"Renal involvement in systemic sclerosis: an update","volume":"45","author":"Chrabaszcz","year":"2020","journal-title":"Kidney Blood Press Res"},{"issue":"25","key":"10.1016\/j.autrev.2023.103330_bb0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM197906213002505","article-title":"Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade","volume":"300","author":"Lopez-Ovejero","year":"1979","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000182028","article-title":"Clinical course of patients with scleroderma renal crisis treated with captopril","volume":"27","author":"Zawada","year":"1981","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2023.103330_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","article-title":"A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study","volume":"75","author":"Elhai","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103330_bb0065","doi-asserted-by":"crossref","first-page":"538589","DOI":"10.1155\/2010\/538589","article-title":"Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy","volume":"2010","author":"Shanmugam","year":"2010","journal-title":"Int J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103330_bb0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","article-title":"Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study","volume":"31","author":"Trostle","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","article-title":"Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment","volume":"42","author":"Kingdon","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009740802629424","article-title":"Renal function is mostly preserved in patients with systemic sclerosis","volume":"38","author":"Scheja","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103330_bb0090","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3899\/jrheum.111417","article-title":"Longitudinal study of renal function in systemic sclerosis","volume":"39","author":"Caron","year":"2012","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200912-1820OC","article-title":"Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension","volume":"182","author":"Campo","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2023.103330_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12882-022-02715-9","article-title":"Central venous pressure and acute kidney injury in critically ill patients with multiple comorbidities: a large retrospective cohort study","volume":"23","author":"Sun","year":"2022","journal-title":"BMC Nephrol"},{"issue":"14","key":"10.1016\/j.autrev.2023.103330_bb0105","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.semarthrit.2009.06.002","article-title":"Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital","volume":"39","author":"Joven","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103330_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5414\/CNP70110","article-title":"Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity","volume":"70","author":"Seiberlich","year":"2008","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103330_bb0120","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00296-013-2691-6","article-title":"Proteinuria in systemic sclerosis: reversal by ACE inhibition","volume":"33","author":"Schuster","year":"2013","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/BOR.0b013e3283108df7","article-title":"Diagnosis, management and prevention of scleroderma renal disease","volume":"20","author":"Penn","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0130","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"issue":"10103","key":"10.1016\/j.autrev.2023.103330_bb0135","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128071-200102050-00006","article-title":"Treatment of systemic sclerosis","volume":"2","author":"Steen","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Group Fran\u00e7ais de Recherche sur le Scl\u00e9rodermie (GFRS). Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","article-title":"Scleroderma renal crisis","volume":"44","author":"Bose","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0160","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/annrheumdis-2014-205226","article-title":"Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database","volume":"74","author":"Maurer","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2023.103330_bb0165","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.22036","article-title":"Endothelin axis polymorphisms in patients with scleroderma","volume":"54","author":"Fonseca","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2023.103330_bb0170","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.autrev.2018.03.012","article-title":"Therapy of scleroderma renal crisis: state of the art","volume":"17","author":"Zanatta","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s100670050132","article-title":"Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis","volume":"18","author":"Kobayashi","year":"1999","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.2008.102400","article-title":"Anti-endothelial cell antibodies in systemic sclerosis","volume":"69","author":"Mihai","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","article-title":"Antiendothelial cell antibodies: useful markers of systemic sclerosis","volume":"102","author":"Salojin","year":"1997","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0190","first-page":"527","article-title":"Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"10 Pt 2","key":"10.1016\/j.autrev.2023.103330_bb0195","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.lpm.2014.02.031","article-title":"Kidney involvement in systemic sclerosis","volume":"43","author":"Steen","year":"2014","journal-title":"Presse Med"},{"issue":"Suppl. 5","key":"10.1016\/j.autrev.2023.103330_bb0200","doi-asserted-by":"crossref","first-page":"v54","DOI":"10.1093\/rheumatology\/ken307","article-title":"Renal manifestations of systemic sclerosis \u2013 clinical features and outcome assessment","volume":"47","author":"Denton","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2023.103330_bb0205","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0210","first-page":"380","article-title":"Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases","volume":"24","author":"Shalev","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103330_bb0215","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/IJGM.S221471","article-title":"Renal pathology and clinical associations in systemic sclerosis: a historical cohort study","author":"Tonsawan","year":"2019","journal-title":"Int J Gen Med"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0220","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3899\/jrheum.131210","article-title":"Scleroderma renal crisis","volume":"41","author":"Mouthon","year":"2014","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000182028","article-title":"Clinical course of patients with scleroderma renal crisis treated with captopril","volume":"27","author":"Zawada","year":"1981","journal-title":"Nephron."},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semarthrit.2012.01.003","article-title":"Treatment of systemic sclerosis complications: what to use when first-line treatment fails \u2013 a consensus of systemic sclerosis experts","volume":"42","author":"Walker","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"25","key":"10.1016\/j.autrev.2023.103330_bb0235","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM197906213002505","article-title":"Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade","volume":"300","author":"Lopez-Ovejero","year":"1979","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2397198320920422","article-title":"Mortality and morbidity in scleroderma renal crisis: A systematic literature review","volume":"6","author":"Kim","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0245","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.ajkd.2005.01.007","article-title":"Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade","volume":"45","author":"Cheung","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"9052","key":"10.1016\/j.autrev.2023.103330_bb0250","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)61568-1","article-title":"Failure of losartan to control blood pressure in scleroderma renal crisis","volume":"349","author":"Caskey","year":"1997","journal-title":"Lancet"},{"issue":"9638","key":"10.1016\/j.autrev.2023.103330_bb0255","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2023.103330_bb0260","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13023-021-01844-y","article-title":"French recommendations for the management of systemic sclerosis","volume":"16","author":"Hachulla","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0265","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med"},{"issue":"2 Suppl 76","key":"10.1016\/j.autrev.2023.103330_bb0270","first-page":"135","article-title":"Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series","volume":"31","author":"Montanelli","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103330_bb0275","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hct111","article-title":"Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility","volume":"106","author":"Penn","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2023.103330_bb0280","author":"US National Library of Medicine"},{"issue":"Suppl. 10","key":"10.1016\/j.autrev.2023.103330_bb0285","article-title":"Bosentan in scleroderma renal crisis: a National Open Label Prospective Study [abstract]","volume":"69","author":"B\u00e9rezn\u00e9","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-0502(01)00078-7","article-title":"Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory markers reflecting disease activity","volume":"25","author":"Cozzi","year":"2001","journal-title":"Transfus Apher Sci"},{"issue":"12","key":"10.1016\/j.autrev.2023.103330_bb0295","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1093\/ndt\/gfs317","article-title":"Prognosis of scleroderma renal crisis: a long-term observational study","volume":"27","author":"Cozzi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.autrev.2023.103330_bb0300","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.transci.2006.05.014","article-title":"Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study","volume":"36","author":"Altuntas","year":"2007","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0310","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1081\/JDI-100107372","article-title":"Thrombotic thrombocytopenic purpura in a case of scleroderma renal crisis treated with twice-daily therapeutic plasma exchange","volume":"23","author":"Kfoury Baz","year":"2001","journal-title":"Ren Fail"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0315","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tmrv.2019.09.004","article-title":"Eculizumab and beyond: the past, present, and future of complement therapeutics","volume":"33","author":"Patriquin","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"10","key":"10.1016\/j.autrev.2023.103330_bb0320","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/anr.1780321011","article-title":"Activation of the complement system in systemic sclerosis. Relationship to clinical severity","volume":"32","author":"Senaldi","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"30","key":"10.1016\/j.autrev.2023.103330_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004459","article-title":"Complement activation and effect of eculizumab in scleroderma renal crisis","volume":"95","author":"Devresse","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103330_bb0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","article-title":"Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis","volume":"18","author":"Okroj","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2023.103330_bb0335","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0340","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ckj\/sfv101","article-title":"Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome","volume":"8","author":"Thomas","year":"2015","journal-title":"Clin Kidney J"},{"issue":"2018","key":"10.1016\/j.autrev.2023.103330_bb0345","first-page":"6051083","article-title":"Scleroderma renal crisis Debute with thrombotic Microangiopathy: A successful Case treated with Eculizumab","author":"Uriarte","year":"2018","journal-title":"Case Rep Nephrol"},{"issue":"30","key":"10.1016\/j.autrev.2023.103330_bb0350","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004459","article-title":"Complement activation and effect of eculizumab in scleroderma renal crisis","volume":"95","author":"Devresse","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0355","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ekir.2021.01.021","article-title":"Role of C5 inhibition in idiopathic inflammatory myopathies and scleroderma renal crisis-induced thrombotic microangiopathies","volume":"6","author":"Gouin","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0360","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11739-019-02096-2","article-title":"Scleroderma renal crisis: a review for emergency physicians","volume":"14","author":"Montrief","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0365","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.autrev.2017.02.012","article-title":"Towards developing criteria for scleroderma renal crisis: a scoping review","volume":"16","author":"Hoa","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0370","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"3 Suppl 29","key":"10.1016\/j.autrev.2023.103330_bb0375","first-page":"S29","article-title":"Assessment of kidney involvement","volume":"21","author":"Steen","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0380","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/art.40809","article-title":"Generation of a Core set of items to develop classification criteria for scleroderma renal crisis using consensus methodology","volume":"71","author":"Butler","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2010.05.018","article-title":"Endothelin-1 expression in scleroderma renal crisis","volume":"42","author":"Mouthon","year":"2011","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103330_bb0390","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0395","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0400","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3899\/jrheum.091048","article-title":"Association of RNA polymerase III antibodies with scleroderma renal crisis","volume":"37","author":"Nguyen","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0405","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis","volume":"63","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0410","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10067-012-1949-9","article-title":"Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis","volume":"31","author":"Yanaba","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0415","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00403-019-01893-1","article-title":"The role of adipokines in systemic sclerosis: a missing link?","volume":"311","author":"\u017b\u00f3\u0142kiewicz","year":"2019","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0420","first-page":"1101","article-title":"Adipokines in connective tissue diseases","volume":"34","author":"Sawicka","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103330_bb0425","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1996.23758.x","article-title":"Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis","volume":"134","author":"Akimoto","year":"1996","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31827781fd","article-title":"Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature","volume":"92","author":"Qu\u00e9m\u00e9neur","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0435","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40001-021-00500-2","article-title":"ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review","volume":"26","author":"Wu","year":"2021","journal-title":"Eur J Med Res"},{"issue":"12","key":"10.1016\/j.autrev.2023.103330_bb0440","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1093\/rheumatology\/keab278","article-title":"ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies","volume":"60","author":"Hughes","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2023.103330_bb0445","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/rheumatology\/ket213","article-title":"Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors","volume":"52","author":"Derrett-Smith","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103330_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103072","article-title":"Kidney disease in antiphospholipid antibody syndrome: risk factors, pathophysiology and management","volume":"21","author":"Scheen","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2023.103330_bb0455","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10067-009-1188-x","article-title":"Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis","volume":"28","author":"Wielosz","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0460","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0465","first-page":"199","article-title":"Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury","volume":"23","author":"Assous","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916939508993333","article-title":"Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis","volume":"20","author":"Picillo","year":"1995","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0475","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.semarthrit.2011.11.005","article-title":"Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis","volume":"41","author":"Rosato","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2023.103330_bb0480","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/acr.22309","article-title":"Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis","volume":"66","author":"Rosato","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.autrev.2023.103330_bb0485","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000489740","article-title":"Prognostic factors of renal involvement in systemic sclerosis","volume":"43","author":"Rosato","year":"2018","journal-title":"Kidney Blood Press Res"},{"issue":"1038","key":"10.1016\/j.autrev.2023.103330_bb0490","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140004","article-title":"Resistive intrarenal index: myth or reality?","volume":"87","author":"Granata","year":"2014","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0495","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/art.1780390622","article-title":"Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy","volume":"39","author":"Rivolta","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103330_bb0500","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2019.09.001","article-title":"The renal resistive index in systemic sclerosis: determinants, prognostic implication and proposal for specific age-adjusted cut-offs","volume":"70","author":"Bruni","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.autrev.2023.103330_bb0505","first-page":"1944","article-title":"Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis","volume":"24","author":"Scorza","year":"1997","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0510","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/030097401316909495","article-title":"D-penicillamine is not an effective treatment in systemic sclerosis","volume":"30","author":"Furst","year":"2001","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103330_bb0515","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.185.1.71","article-title":"Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis","volume":"185","author":"Casciola-Rosen","year":"1997","journal-title":"J Exp Med"},{"issue":"6629","key":"10.1016\/j.autrev.2023.103330_bb0520","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/bmj.296.6629.1083","article-title":"Natural course of penicillamine nephropathy: a long term study of 33 patients","volume":"296","author":"Hall","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0525","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0749-0704(01)00004-5","article-title":"Thrombotic microangiopathies","volume":"18","author":"Halevy","year":"2002","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.autrev.2023.103330_bb0530","doi-asserted-by":"crossref","first-page":"543704","DOI":"10.1155\/2010\/543704","article-title":"Scleroderma renal crisis: a pathology perspective","volume":"2010","author":"Batal","year":"2010","journal-title":"Int J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103330_bb0535","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/ajkd.2001.24516","article-title":"Relationship between underlying renal disease and renal transplantation outcome","volume":"37","author":"Bleyer","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.autrev.2023.103330_bb0540","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","article-title":"Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature","volume":"5","author":"Pham","year":"2005","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.autrev.2023.103330_bb0545","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1600-6143.2004.00605.x","article-title":"Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity","volume":"4","author":"Gibney","year":"2004","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.autrev.2023.103330_bb0550","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/tri.12923","article-title":"Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study","volume":"30","author":"Bertrand","year":"2017","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0555","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.ajkd.2018.05.016","article-title":"Characteristics and outcomes of patients with systemic sclerosis (scleroderma) requiring renal replacement therapy in Europe: results from the ERA-EDTA registry","volume":"73","author":"Hruskova","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0560","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000186579","article-title":"Progressive systemic sclerosis and renal transplantation: a contraindication to ciclosporin","volume":"59","author":"Ruiz","year":"1991","journal-title":"Nephron."},{"issue":"4","key":"10.1016\/j.autrev.2023.103330_bb0565","first-page":"2211","article-title":"Sanz de Castro S, Arias M. progressive systemic sclerosis and renal transplantation: a contraindication to the use of cyclosporine A?","volume":"23","author":"Ruiz","year":"1991","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.autrev.2023.103330_bb0570","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10067-013-2422-0","article-title":"Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries","volume":"33","author":"Iudici","year":"2014","journal-title":"Clin Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:29:01Z","timestamp":1761600541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":114,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1568997223000642"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103330","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal involvement in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103330"}}